InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-2.4%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Peck Ronald, Directeur Médical. Director active across 1 company, notably Arvinas, INC.. In total, 13 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €158k. Activity tracked since 30 June 2021. The latest transaction was filed on 23 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
39,250 shares0Common StockSEC:0001655759-24-000026:0
1,699 shares@ US$47.052.5% of flowCommon StockSEC:0001655759-24-000026:1
4,010 sharesCommon StockSEC:0001655759-23-000081:0
19,125 shares0Common StockSEC:0001655759-23-000019:0
4,010 sharesCommon StockSEC:0001655759-22-000034:0
4,010 sharesCommon StockSEC:0001655759-22-000032:0
1,258 shares@ US$68.9942.8% of flowCommon StockSEC:0001655759-22-000032:1
14,375 shares@ US$47.3820.3% of flowCommon StockSEC:0001209191-22-001202
14,375 shares@ US$47.380.079% mcap21.4% of flowCommon StockSEC:0001209191-22-001202:0
4,011 sharesCommon StockSEC:0001209191-21-051729
4,011 sharesCommon StockSEC:0001209191-21-051729:0
20,000 shares@ US$47.3827.0% of flowCommon StockSEC:0001209191-21-045192
20,000 shares@ US$47.380.10% mcap28.6% of flowCommon StockSEC:0001209191-21-045192:0
13 of 13 declarations
About Peck Ronald
Ronald Peck is the Chief Medical Officer at Arvinas, Inc. He is responsible for overseeing the company's medical and research initiatives. Peck plays a key role in developing clinical strategies and optimizing research processes. His medical expertise is essential for ensuring compliance and efficiency in medical operations.
